The human papilloma virus, the vaccines, and oral and oropharyngeal squamous cell carcinoma: What every dentist should know

General Dentistry

Volumn 55, Issue 3, 2007, Pages 252-254

  Closmann, James J ^a  

^a TRIPLER ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAPILLOMA VIRUS VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALPHAPAPILLOMAVIRUS; ARTICLE; CHILD; CLASSIFICATION; FEMALE; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; MIDDLE AGED; MOUTH TUMOR; OROPHARYNX TUMOR; RISK FACTOR; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; CHILD; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 34247586784     PISSN: 03636771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Lowy DR, Schiller JT. Prophylactic human papillomavirus vaccines. J Clin Invest 2006;116:1167-1173.
2. Steinbrook R. The potential of human papillomavirus vaccines. N Engl J Med 2006;354:1109-1112.
3. Villa LL. Prophylactic HPV vaccines: Reducing the burden of HPV-related diseases. Vaccine 2006;24 Suppl 1:S23-S28.
4. Gillison ML, Shah KV. Chapter 9: Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr 2003;(31):57-65.
5. Syrjanen K, Syrjanen S, Lamberg M, Pyrhonen S, Nuutinen J. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 1983;12:418-424.
6. Chang F, Syrjanen S, Nuutinen J, Karja J, Syrjanen K. Detection of human papillomavirus (HPV) DNA in oral squamous cell carcinomas by in situ hybridization and polymerase chain reaction. Arch Dermatol Res 1990;282:493-497.
7. Snijders PJ, Scholes AG, Hart CA, Jones AS, Vaughan ED, Woolgar JA, Meijer CJ, Walboomers JM, Field JK, Prevalence of mucosotropic human papilloma viruses in squamous-cell carcinoma of the head and neck. Int J Cancer 1996;66:464-469.
8. Snijders PJ, Steenbergen RD, Meijer CJ, Walboomers JM. Role of human papillomaviruses in cancer of the respiratory and upper digestive tract. Clin Dermatol 1997;15:415-425.
9. Badaracco G, Venuti A, Morello R, Muller A, Marcante ML. Human papillomavirus in head and neck carcinomas: Prevalence, physical status and relationship with clinical/pathological parameters. Anticancer Res 2000;20:1301-1305.
10. De Petrini M, Ritta M, Schena M, Chiusa L, Campisi P, Giordano C, Landolfo V, Pecorari G, Landolfo S. Head and neck squamous cell carcinoma: Role of the human papillomavirus in tumour progression. New Microbiol 2006;29:25-33.
11. Hansson BG, Rosenquist K, Antonsson A, Wennerberg J, Schildt EB, Bladstrom A, Andersson G. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: A population-based case-control study in southern Sweden. Acta Otolaryngol 2005;125:1337-1344.
12. Syrjanen S. Human papilloma virus (HPV) in head and neck cancer. J Clin Virol 2005;32 Suppl 1:S59-66.
13. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: A meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:622-635.
14. Maden C, Beckmann AM, Thomas DB, McKnight B, Sherman KJ, Ashley RL, Corey L, Daling JR. Human papilloma viruses, herpes simplex viruses, and the risk of oral cancer in men. Am J Epidemiol 1992;135:1093-1102.
15. Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH. Human papillomavirus and risk of oral cancer. Laryngoscope 1998;108:1098-1103.
16. Schmidt BL, Dierks EJ, Homer L, Potter B. Tobacco smoking history and presentation of oral squamous cell carcinoma. J Oral Maxillofac Surg 2004;62:1055-1058.
17. Sheil AG. Organ transplantation and malignancy: Inevitable linkage. Transplant Proc 2002;34:2436-2437.
18. Harris JP, Penn I. Immunosuppression and the development of malignancies of the upper airway and related structures. Laryngoscope 1981;91:520-528.
19. Hernandez G, Arriba L, Jimenez C, Bagan JV, Rivera B, Lucas M, Moreno E. Rapid progression from oral leukoplakia to carcinoma in an immunosuppressed liver transplant recipient. Oral Oncol 2003;39:87-90.
20. de Visscher JG, Bouwes Bavinck JN, van der Waal I. Squamous cell carcinoma of the lower lip in renal-transplant recipients. Report of six cases. Int J Oral Maxillofac Surg 1997;26:120-123.
21. Meng S, Jiamei L. Management of tongue cancer in the patient who is systemically immunosuppressed: A preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:689-693.
22. Al-Bakkal G, Ficarra G, McNeill K, Eversole LR, Sterrantino G, Birek C. Human papilloma virus type 16 E6 gene expression in oral exophytic epithelial lesions as detected by in situ rtPCR. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:197-208.
23. Wu JJ, Orengo IF. Squamous cell carcinoma in solid-organ transplantation. Dermatol Online J 2002;8:4.
24. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G; HPV Vaccine Study Group. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial. Lancet 2006;367:1247-1255.
25. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
26. Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, Garnett GP. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: Mathematical modelling analyses. PLoS Med 2006;3:e138.
27. ScullyC. Oral cancer; the evidence for sexual transmission. Br Dent J 2005;199:203-207.